149 related articles for article (PubMed ID: 25124628)
1. Is the neutrophil-lymphocyte ratio an indicator of progression in patients with benign prostatic hyperplasia?
Tanik S; Albayrak S; Zengin K; Borekci H; Bakirtas H; Imamoglu MA; Gurdal M
Asian Pac J Cancer Prev; 2014; 15(15):6375-9. PubMed ID: 25124628
[TBL] [Abstract][Full Text] [Related]
2. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E
Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069
[TBL] [Abstract][Full Text] [Related]
3. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
4. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
Jhang JF; Jiang YH; Kuo HC
Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
[TBL] [Abstract][Full Text] [Related]
5. Role of Neutrophil to Lymphocyte Ratio or Platelet to Lymphocyte Ratio in Prediction of Bone Metastasis of Prostate Cancer.
Zhang JY; Ge P; Zhang PY; Zhao M; Ren L
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115239
[TBL] [Abstract][Full Text] [Related]
6. Can we use neutrophil to lymphocyte ratio in the diagnosis and prediction of extracapsular extension in localized prostate cancer?
Merder E; Arıman A; Dinçer S; Altunrende F
Urologia; 2022 May; 89(2):203-209. PubMed ID: 33960239
[TBL] [Abstract][Full Text] [Related]
7. Subtypes of white blood cells in patients with prostate cancer or benign prostatic hyperplasia and healthy individuals.
Cihan YB; Arslan A; Ergul MA
Asian Pac J Cancer Prev; 2013; 14(8):4779-83. PubMed ID: 24083743
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].
Zhang HT; Xu Y; Chang JW; Zhang ZH; Liu RL; Ma BJ
Zhonghua Nan Ke Xue; 2012 Mar; 18(3):208-11. PubMed ID: 22474983
[TBL] [Abstract][Full Text] [Related]
9. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
Zhao S; Tang J; Shao S; Yan Y
Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.
Kaynar M; Yildirim ME; Gul M; Kilic O; Ceylan K; Goktas S
Cancer Biomark; 2015; 15(3):317-23. PubMed ID: 25586096
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-lymphocyte and neutrophil-to-monocyte rates in the decision for a prostate re-biopsy in patients with a previous benign pathology and consistently 2,5-10 ng/ml PSA value.
Ceylan Y; Günlüsoy B; Degirmenci T; Bolat D; Kozacioglu Z; Vardar E; Topçu YK; Polat S
Arch Esp Urol; 2016 Nov; 69(9):627-635. PubMed ID: 27845694
[TBL] [Abstract][Full Text] [Related]
13. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
Lee JH; Kim Y; Park YW; Lee DG
J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of the Platelet-To-Lymphocyte Ratio in Diagnosis of Prostate Cancer.
Yuksel OH; Urkmez A; Akan S; Yldirim C; Verit A
Asian Pac J Cancer Prev; 2015; 16(15):6407-12. PubMed ID: 26434851
[TBL] [Abstract][Full Text] [Related]
15. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
Inamura S; Ito H; Shinagawa T; Tsutsumiuchi M; Taga M; Kobayashi M; Yokoyama O
Prostate; 2018 Jul; 78(10):743-752. PubMed ID: 29608020
[TBL] [Abstract][Full Text] [Related]
16. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.
Yin Z; Yang JR; Rao JM; Song W; Zhou KQ
Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137
[TBL] [Abstract][Full Text] [Related]
17. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
[TBL] [Abstract][Full Text] [Related]
18. The role of inflammatory processes and zinc levels in prostatic enlargement among Iraqi samples.
Sameen AM; Shabeeb IA; Rashied RM
J Med Life; 2023 Sep; 16(9):1388-1392. PubMed ID: 38107701
[TBL] [Abstract][Full Text] [Related]
19. The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study.
Fu Y; Zhou Z; Yang B; Zhang K; He L; Zhang X
Urol Int; 2016; 97(3):330-335. PubMed ID: 27509202
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of neutrophil-to-lymphocyte ratio as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy.
Lu Y; Huang HH; Lau WKO
World J Urol; 2020 Jan; 38(1):103-109. PubMed ID: 30953141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
